FIELD: organic chemistry, medicine, pharmacology, pharmacy.
SUBSTANCE: invention relates to using compound of the formula (I) 
for preparing a medicinal agent used in treatment of disturbances associated with gastrin, and to a method for treatment of these disorders, a pharmaceutical composition used in treatment of said disturbances and containing a proton pump inhibitor, and a compound of the formula (I). Also, invention relates to a method for preparing the pharmaceutical composition, a set containing a compound of the formula (I) and the proton pump inhibitor. Also, invention relates to novel compounds of formulas (IIa) 
and (IIb) 
. Invention provides the enhanced effectiveness of treatment.
EFFECT: improved, enhanced and valuable properties of compounds and pharmaceutical composition.
50 cl, 1 tbl, 160 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VASOPRESSIN V RECEPTOR ANTAGONISTS | 2005 |
|
RU2370497C2 |
| DIPHENYL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT | 1997 |
|
RU2175319C2 |
| SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
| DERIVATIVES OF 3-SUBSTITUTED 4-ARYLQUINOLIN-2-ONE AS MODULATORS OF POTASSIUM CHANNEL | 1999 |
|
RU2240998C2 |
| 3-OXO-3,9-DIHYDRO-1H-CHROMENO[2,3-c] PYRROLES AS GLUCOKINASE ACTIVATORS | 2011 |
|
RU2603191C2 |
| RETINOID-LIKE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1996 |
|
RU2163590C2 |
| DERIVATIVES OF HETEROARYLCARBAMOYLBENZENE | 2004 |
|
RU2330030C2 |
| ADAMANTYL DERIVATIVES USEFUL FOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2626890C2 |
| INHIBITORS OF AKT ACTIVITY | 2010 |
|
RU2579513C2 |
| PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS | 2008 |
|
RU2464262C2 |
